These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26658085)

  • 1. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
    Kelty E; Hulse G; Joyce D; Preen DB
    CNS Drugs; 2020 Jun; 34(6):629-642. PubMed ID: 32215842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications for Opioid Use Disorder: A Guide for Physicians.
    Azhar N; Chockalingam R; Azhar A
    Mo Med; 2020; 117(1):59-64. PubMed ID: 32158052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
    Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
    Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine implants (Probuphine) for opioid dependence.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
    [No Abstract]   [Full Text] [Related]  

  • 8. Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
    Lescut C; Gaboriau L; Carton L; Rolland B
    J Clin Psychopharmacol; 2017 Oct; 37(5):631-633. PubMed ID: 28806388
    [No Abstract]   [Full Text] [Related]  

  • 9. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
    Clark N; Verster A
    Addiction; 2013 Feb; 108(2):253-5. PubMed ID: 23331880
    [No Abstract]   [Full Text] [Related]  

  • 10. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.
    Morgan JR; Schackman BR; Weinstein ZM; Walley AY; Linas BP
    Drug Alcohol Depend; 2019 Jul; 200():34-39. PubMed ID: 31082666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence.
    Ramdurg S; Ambekar A; Lal R
    J Sex Med; 2012 Dec; 9(12):3198-204. PubMed ID: 21366875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
    Sekar V; Tomaka F; Lefebvre E; De Pauw M; Vangeneugden T; van den Brink W; Hoetelmans R
    J Clin Pharmacol; 2011 Feb; 51(2):271-8. PubMed ID: 20421512
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Elias AM; Pepin MJ; Brown JN
    J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
    Shulman M; Wai JM; Nunes EV
    CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.
    Diot C; Eiden C; Roussin A; Batisse A; Boucher A; Chavant F; Daveluy A; Donadieu-Rigole H; Peyrière H;
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1539-40. PubMed ID: 26329380
    [No Abstract]   [Full Text] [Related]  

  • 17. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 18. Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.
    Jhugroo A; Ellayah D; Norman A; Hulse G
    J Psychopharmacol; 2014 Aug; 28(8):800-3. PubMed ID: 24695742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine maintenance therapy hinders acute pain management in trauma.
    Harrington CJ; Zaydfudim V
    Am Surg; 2010 Apr; 76(4):397-9. PubMed ID: 20420250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.